2022: the year in cardiovascular disease - the year of upfront lipid lowering combination therapy

Autor:	Maciej Banach, Zeljko Reiner, Arrigo Cicero, Pierre Sabouret, Margus Viigimaa, Amirhossein Sahebkar, Arman Postadzhiyan, Dan Gaita, Daniel Pella, Peter Penson
Přispěvatelé:	Banach M, Reiner Z, Cicero AFG, Sabouret P, Viigimaa M, Sahebkar A, Postadzhiyan A, Gaita D, Pella D, Penson PE
Rok vydání:	2022
Předmět:	General Medicine Year cardiovascular disease lipid
Zdroj:	Archives of medical science : AMS. 18(6)
ISSN:	1734-1922
Popis:	Recent data clearly show that we are extremely ineffective in the use of lipid-lowering therapy (LLT). Furthermore, the problem seems to be the most serious in the group of patients at very high and extremely high-risk – the patients who stand to benefit most from effective therapy.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f51b98b6f753633cfb27bc2f37e3d4c https://pubmed.ncbi.nlm.nih.gov/36457968 Zobrazit plný text záznamu Plný text ve formátu PDF